SCHEMBL6713451

SCHEMBL6713451

CCCCC(CC)C(=O)Nc1cccc2cc(C(=O)Nc3ccc(C#N)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 4/20 0.35
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
PLA2G7 Q13093 9/20 0.34
KMT2A Q03164 2/20 0.33
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
GSK3B P49841 1/20 0.32
PLA2G10 O15496 1/20 0.32
PLA2G1B P04054 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G5 P39877 1/20 0.32
PTK2 Q05397 1/20 0.32
PTK2B Q14289 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707904 0.94 MAPT (0.37) L3MBTL1MAPTMAPK1TDP1PLA2G7
SCHEMBL6708780 0.89 GRIK1 (0.38) L3MBTL1MAPTMAPK1TDP1PLA2G7
SCHEMBL6707703 0.89 GRIK1 (0.40) L3MBTL1MAPTMAPK1TDP1PLA2G7
SCHEMBL6711354 0.89 MAPT (0.39) MAPTMAPK1TDP1PLA2G7POLB
SCHEMBL6710292 0.88 GSK3B (0.40) MAPTMAPK1TDP1PLA2G7POLB
SCHEMBL6711656 0.88 GSK3B (0.42) MAPTMAPK1TDP1PLA2G7POLB
SCHEMBL6713357 0.87 HDAC3 (0.41) MAPTMAPK1TDP1PLA2G7POLB
SCHEMBL6713665 0.87 HDAC3 (0.41) MAPTMAPK1TDP1PLA2G7POLB
SCHEMBL6710226 0.87 TP53 (0.43) MAPTKMT2APOLBMEN1SMN1; SMN2
SCHEMBL6710195 0.86 MAPT (0.39) MAPTMAPK1TDP1PLA2G7POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 L3MBTL1 2013/4885MAPT 4754/4885MAPK1 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.